Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2019 / Cilt: 29 - Sayı: 3

Severe Cardiac and Renal Findings in an Adolescent Girl: Trandolapril/Verapamil Hydrochloride Overdose

Bir Adolesan Kızda Trandolapril/Verapamil Hidroklorür Kombinasyon Toksisitesi İle Ciddi Kardiyak ve Renal Bulgular

Pages
302–306
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case was reported in orderto present findings of cardiac and renal toxicity which may develop due to the use of fixed-dose combination drugssuch as trandolapril/verapamil hydrochloride that are rarely prescribed in childhood and adolescent age group

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Trandolapril/verapamil hydrochloride combination is an antihypertensive drug.
📊
Key Findings & Data:A 15-year-old female patient wasbrought to our hospital with the findings of fatigue and somnolence.
💡
Conclusion & Impact:This case was reported in orderto present findings of cardiac and renal toxicity which may develop due to the use of fixed-dose combination drugssuch as trandolapril/verapamil hydrochloride that are rarely prescribed in childhood and adolescent age group
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Trandolapril/verapamil hydrochloride combination is an antihypertensive drug. A 15-year-old female patient wasbrought to our hospital with the findings of fatigue and somnolence. It was learnt that 12 hours before her admittance, she had taken tablets each containing 180 mg verapamil and 2 ml trandolapril. Temporary pacemaker wasimplanted to the patient for monitorization who had clinical picture of bradycardia, hypotension and acute renalfailure and appropriate fluid treatment was administered. Pacemaker was removed after 12 hours because normalheart rhythm was restored. Acute renal failure was resolved with fluid replacement. This case was reported in orderto present findings of cardiac and renal toxicity which may develop due to the use of fixed-dose combination drugssuch as trandolapril/verapamil hydrochloride that are rarely prescribed in childhood and adolescent age group

Özet

Trandolapril/Verapamil Hidroklorid kombinasyonu bir antihipertansif ilaçtır. 15 yaşında kız hasta hastanemize halsizlik ve somnolans bulguları ile getirildi. Başvurusundan 12 saat önce her bir tabletinde 180 mg verapamil ve 2 mg trandolapril bulunan tabletlerden içtiği öğrenildi. Bradikardi, hipotansiyon ve akut böbrek hasarı tablosunda olan hastaya izlem amaçlı geçici pacemaker takılarak uygun sıvı replasmanı sağlandı. Normal kalp ritminin sağlanmasından 12 saat sonra pacemaker çıkarıldı. Akut böbrek hasarı sıvı tedavisi ile düzeldi.Bu vaka çocukluk ve adolesan çağda Trandalopril/Verapamil gibi sabit doz da ilaç kombinasyonları içeren ve çocukluk çağında kullanımı nadir olan ilaçların toksisitesi ile ilgili gelişebilecek kardiyak ve renal toksisite bulgularını sunmak için yazılmıştır.

🔖

Cite This Article

ORBATU, D., ALAYGUT, D., OFLAZ, M. B. (2022). Severe Cardiac and Renal Findings in an Adolescent Girl: Trandolapril/Verapamil Hydrochloride Overdose. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 29 - Sayı: 3, 302–306. https://ajindex.com/articles/558097

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Steven G. Chrysant using fixed-dose combination therapies to achieve blood pressure goals. Clin Drug Invest. 2008;28(11):713-34. [CrossRef] 2. Pepine CJ, Handberg EM, Cooper-DeHoff RM et al. A calcium, antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international Verapamil-Trandolapril Study (INVEST). A randomized controlled trial. JAMA. 2003;290(21):2805-16. [CrossRef] 3. Doğan M, Basaranoglu M, Peker E, Akbayram S, Sahin M, Uner A, et al. Tarka overdose in a young child. Human and Experimental Toxicology 30(9):1392-1398. [CrossRef] 4. Nick I. Batalis, Russell A. Harley and cynthia a. Schandl verapamil toxicity an unusual case report and review of the literature. The American Journal of Forensic Medicine and Pathology. 2007;28:2. [CrossRef] 5. Tarka, Physicians’ Desk Reference, 59th ed. Montvale, NJ: Thomson PDR; 2005. 6. Ruggenenti P, Fassi A, Ilieva AP, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351:1941-51. [CrossRef] 7. Samniah N and Schlaeffer F. Cerebral infarction associated with oral verapamil overdose. J Toxicol Clin Toxicol. 1988;26:365-9. [CrossRef] 8. Shah AR and Passalacqua BR. Case report: sustained release verapamil overdose causing stroke: an unusual complication. Am J Med Sci. 1992;304:357-9. [CrossRef] 9. Barrow PM, Houston PL and Wong DT. Overdose of sustainedrelease verapamil. Br J Anaesth. 1994;72:361-5. [CrossRef] 10. Rankin RJ and Edwards IR. Overdose of sustained release verapamil. N Z Med J. 1990;103:165. 11. Cohen V, Jellinek SP, Fancher L, Sangwan G, Wakslak M, Marquart E, et al. Tarka(R) (Trandolapril/Verapamil hydrochloride extended-release) overdose. J Emerg Med. 2011;3:291-5. [CrossRef] 12. Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci. 1995;310:258-63. 13. Ramoska EA, Spiller HA, Myers A. Calcium channel blocker toxicity. Ann Emerg Med. 1990;19:649-53. [CrossRef] 14. Gokel Y, Paydas S, and Duru M. High-dose verapamil trandolapril induced rhabdomyolysis and acute renal failure. Am J Emerg Med. 2000;18:738-9. [CrossRef] 15. Gokel Y, Paydas S, Acikalin A, Bozkurt A. High-doseverapamil and trandolapril-induced thrombotic microangiopathy. Haematologia (Budap). 2002;32:281-5. [CrossRef] 16. Batalis NI, Harley RA, Schandl CA. Verapamil toxicity: an unusual case report and review of the literature. Am J Forensic Med Pathol. 2007;2